Related by context. All words. (Click for frequent words.) 72 Lazard Capital 70 Thomas Weisel Partners 66 Piper Jaffray 65 CE Unterberg Towbin 64 Pacific Growth Equities 64 SG Cowen 63 Thomas Weisel 62 Canaccord Genuity 61 JMP Securities LLC 61 ThinkEquity LLC 61 Kaufman Brothers 60 ThinkEquity Partners 60 WR Hambrecht 60 Canaccord Adams 60 Brean Murray Carret 60 Wedbush Securities 59 ThinkEquity 59 Kaufman Bros. 58 & Renshaw 58 JP Morgan Securities 58 ThinkEquity Partners LLC 57 Brean Murray 57 Leerink Swann 57 Wachovia Capital Markets 57 Craig Hallum Capital 56 Wedbush 56 Adams Harkness 56 Citi Investment 55 Kaufman Bros 55 ThinkEquity analyst 55 Merriman Curhan Ford 55 SunTrust Robinson 55 Stifel Nicolaus 55 Leerink Swan 55 JP Morgan 54 RBC Capital Markets 54 Sidoti & 54 Piper Jaffray analyst 54 W. Baird 54 analyst Ajit Pai 54 Leerink Swann LLC 54 Chardan Capital Markets 54 Wedbush Morgan Securities 53 UBS Investment 53 KeyBanc Capital Markets 53 Auriga USA 53 WR Hambrecht analyst 53 Janney Montgomery Scott 53 Barclays Capital 53 Ardour Capital 53 Jeffrey Frelick 52 Joel Sendek 52 CE Unterberg 52 Caris & 52 Broadpoint Capital 52 Broadpoint AmTech 52 analyst Robert Cihra 52 Vijay Rakesh 52 Wedbush Morgan 52 Piper Jaffrey 52 JMP Securities 52 ThinkPanmure 52 Nollenberger Capital 51 JMP Securities analyst 51 FTN Midwest 51 Fulcrum Global Partners 51 Bancorp Piper Jaffray 51 analyst Rommel Dionisio 51 Cochran Caronia Waller 51 Jefferies 51 Kalpesh Kapadia 51 analyst Peter Misek 51 ANALYST TAKE Stifel Nicolaus 51 Piper Jaffray PJC 51 Broadpoint Amtech 50 Daniel Berenbaum 50 Prudential Equity 50 analyst Jonathan Aschoff 50 Gerard Klauer Mattison 50 Schwab Soundview 50 PiperJaffray 50 Raj Denhoy 50 RW Baird 50 SG Cowen Securities 50 BWS Financial 50 Sterne Agee 50 analyst Liana Moussatos 50 RW Baird analyst 50 Kaufman Bros. analyst 50 Suntrust Robinson Humphrey 50 Wunderlich Securities 50 Barton Crockett 50 analyst Amit Hazan 50 Natixis Bleichroeder 50 Dahlman Rose & 50 analyst Shebly Seyrafi 49 analyst Glenn Novarro 49 Eric Ende 49 analyst Tore Svanberg 49 Credit Suisse 49 analyst Eric Beder 49 CJS Securities 49 Susquehanna Financial 49 RBC Capital 49 Wedbush analyst 49 Lauren Cooks Levitan 49 analyst Randal Konik 49 Satya Chillara 49 Hamed Khorsand 49 Joel Fishbein 49 JoAnne Feeney 49 Phil Nalbone 49 Ken Cacciatore 49 analyst Adrienne Tennant 49 analyst Raj Denhoy 49 PiperJaffray analyst 49 analyst Youssef Squali 49 Credit Suisse First 49 Neely Tamminga 48 Dr. Jim Birchenough 48 ThinkEquity downgraded 48 BofA Merrill Lynch 48 Piper Jaffray nyse PJC 48 Wedbush Morgan analyst 48 JP Morgan SMid Cap 48 Brigantine Advisors 48 WR Hambrecht + 48 Friedman Billings Ramsey 48 Keay Nakae 48 Wedbush Morgan reiterate 48 Rajesh Ghai 48 Telsey Advisory Group 48 Craig Hallum 48 Hapoalim Securities 48 Oppenheimer OPY 48 analyst Tony Wible 48 analyst Alex Gauna 48 Piper Jaffray Cos. 48 Analyst Cai von 48 Caris 48 analyst William Tanona 48 Natexis Bleichroeder 48 Needham Growth Conference 47 analyst Kristine Koerber 47 Janney Capital Markets 47 Broadpoint.AmTech analyst 47 Ardour Capital Investments 47 Randal Konik 47 analyst Joanne Wuensch 47 Tenthoff 47 analyst Tim Klasell 47 Camilo Lyon 47 Jonathan Ruykhaver 47 analyst Jim Reddoch 47 Dresdner Kleinwort Wasserstein 47 ANALYST TAKE Jefferies 47 SoundView Technology Group 47 analyst Charles Grom 47 Jesse Pichel 47 Chris Shibutani 47 Capstone Investments 47 Piper Jaffray reiterates 47 MDB Capital Group 47 Betsy Van Hees 47 Sanford C. Bernstein 47 reaffirmed Outperform rating 47 SoundView 47 A. Sasa Zorovic 47 Wachovia Securities 47 Rodman Renshaw 47 Banc 47 JMP Securities Research 47 Cai von Rumohr 47 Tao Levy 47 Jeff Klinefelter 47 Eric Beder 47 Stifel Nicholas 47 Kochnover 47 Sara Michelmore 47 ThinkEquity Partners analyst 47 Jay Srivatsa 47 Liana Moussatos 46 Avian Securities 46 Stanicky 46 Feltl 46 FTN Midwest Securities 46 BMO Capital Markets 46 Leerink 46 Mark Schoenebaum 46 Annabel Samimy 46 Adrienne Tennant 46 Broadpoint AmTech analyst 46 Rob Cihra 46 Annual ICR XChange 46 Geoffrey Meacham 46 Annual Needham 46 Stifel Nicolaus Weisel 46 analyst Greg Mesniaeff 46 Versant Partners 46 analyst Gene Munster 46 Vishal Shreedhar 46 Sanford Bernstein 46 Canaccord Adams analyst 46 Canaccord Genuity Cardiovascular 46 analyst Geoffrey Meacham 46 Nathan Schneiderman 46 Jon LeCroy 46 Annual Piper Jaffray 46 Gene Munster Piper Jaffray 46 Fox Pitt Kelton 46 Howard Tubin 46 analyst Anthony Chukumba 46 Matt DiFrisco 46 Akhtar Samad 46 Cory Kasimov 46 Brigantine Advisors analyst 46 Sandler O'Neill + 46 analyst Ehud Gelblum 46 Michael Cristinziano 46 Rachael Rothman 46 analyst Bruce Cranna 46 WR Hambrecht reiterate 46 analyst Randall Stanicky 46 analyst Louis Miscioscia 46 analyst Tristan Gerra 46 analyst Mark Monane 46 Lawrence Keusch 46 Sanjay Shrestha 46 analyst Bruce Nudell 46 Bret Holley 46 Joseph Pantginis 46 analyst Katherine Egbert 45 Unterberg Towbin 45 Eric Coldwell 45 analyst Dinesh Moorjani 45 Neely JN Tamminga 45 analyst Ananda Baruah 45 UBS Warburg LLC 45 Feltl & 45 JPMorgan 45 Stifel Nicholaus 45 Stifel Nicolaus analyst 45 NASDAQ ARIA 45 analyst Tim Savageaux 45 Needham Biotechnology 45 Nicholas Aberle 45 Morgan Stanley 45 Bert Hazlett 45 ICR XChange Conference 45 J. Fassler 45 Oppenheimer 45 Edward Tenthoff 45 analyst Sasa Zorovic 45 Eric Martinuzzi 45 KeyBanc 45 analyst Lawrence Keusch 45 analyst Ajay Jain 45 Leerink Swann analyst 45 FBR Capital Markets 45 Paul Lejuez 45 Deutsche Bank 45 analyst Walter Piecyk 45 Seyrafi 45 THE OPINION 45 Yaron Werber 45 P. Klinefelter 45 DnB NOR Markets 45 Lead Bookrunning Manager 45 Schwab SoundView 45 analyst Ken Trbovich 45 MKM Partners analyst 45 analyst Matthew DiFrisco 45 analyst Safa Rashtchy 45 analyst Allan Mishan 45 Natixis Bleichroeder Hidden Gems 45 analyst Mark Schoenebaum 45 Glen Yeung 45 Bill Shope 45 UBS Warburg 45 Thomas Weisel Partners Tech# 45 Jeffrey Klinefelter 45 Oppenheimer NYSE OPY 45 Anthony Gikas 45 Joanne Wuensch 45 Scot Ciccarelli 45 Kaufman Bros. Investor 45 J.P. Morgan Healthcare 45 Matt Nemer 45 Katherine Egbert 45 analyst Kimberly Greenberger 45 Co. analyst Shebly 44 Calyon Securities USA 44 Tad Piper 44 Shawn Milne 44 analyst Maynard Um 44 Boenning & 44 Keybanc Capital Markets 44 BMO Capital 44 FBR Capital NASDAQ FBCM 44 Suji De Silva 44 analyst Cory Kasimov 44 Matthew Sheerin 44 Cannacord Genuity 44 CE Unterberg Towbin Emerging 44 analyst Hans Mosesmann 44 T. Kron 44 Matthew Kather 44 Monness Crespi Hardt 44 analyst Richard Kugele 44 Peter Goldmacher 44 Scott Mushkin 44 analyst Colby Synesael 44 Schwab Soundview Capital Markets 44 ANALYST TAKE Bear Stearns 44 analyst Kathryn Huberty 44 JPMorgan Basics 44 Morgan Joseph TriArtisan 44 Quynh Pham 44 Jeff Fidacaro 44 analyst Yair Reiner 44 BioCentury Future Leaders 44 analyst Patrick Walravens 44 Cannacord Adams 44 sole bookrunning manager 44 Sarah Friar 44 Cochran Caronia 44 analyst Gil Luria 44 Goldman Sachs 44 Miller Tabek 44 Canaccord Adams Hepatitis C 44 Avondale Partners 44 BernsteinResearch analyst 44 Soleil Securities 44 Wedbush Morgan California Dreamin 44 Needham Growth 44 Calyon Securities analyst Shebly 44 analyst Howard Tubin 44 Michael Masdea 44 analyst Robert Drbul 44 analyst Uche Orji 44 Tore Svanberg 44 Janney Montgomery 44 Geoff Meacham 44 RBC Capital NYSE RY 44 Jefferies NYSE JEF 44 Ehrenkrantz King Nussbaum 44 Merriman Curhan 44 Wolfe Trahan 44 analyst Margaret Mager 44 Broadpoint.AmTech 44 analyst Jami Rubin 44 A. Reitzes 44 Arnie Berman 44 analyst Edward Yruma 44 Cantor Fitzgerald reiterates 44 ANALYST TAKE JP Morgan 44 ThinkPanmure LLC 44 analyst Mitch Kummetz 44 analyst Satya Chillara 44 Sandler O'Neill 44 Nasdaq SLXP 44 analyst Adrianne Shapira 44 Desjardins Securities 44 Moussatos 44 Walter Nasdeo 44 Needham Growth Stock 44 Dresdner Kleinwort 44 Sam Poser 44 analyst Steven Wieczynski 44 CLSA 44 Amy Noblin 44 Edwin Mok 44 Merrill Lynch Tradebot 43 Equinet AG 43 Kristine Koerber 43 JMP Securities downgraded 43 ANALYST TAKE JPMorgan 43 Joe Osha 43 Ramesh Misra 43 JMP Securities Healthcare 43 Kaufman Bros analyst 43 CJS Securities 8th 43 Broadpoint Amtech analyst 43 J.P. Morgan SMid Cap 43 analyst Richard Fetyko 43 Global Healthcare Unplugged 43 Benjamin Schachter 43 Mike Krensavage 43 Acumen BioFin Rodman 43 Lazard 43 Equinet 43 Robert Cihra 43 analyst Christa Quarles 43 Versant Partners analyst 43 SoundView Technology 43 Daniel Fannon 43 Bruce Cranna 43 Panmure Gordon 43 Dhulsini de Zoysa 43 analyst Lawrence Klatzkin 43 CIBC World 43 Annual JMP Securities 43 analyst Brent Thill 43 Ahmar Zaman 43 analyst Curtis Shauger 43 Michael Krensavage 43 HC Wainwright 43 analyst Kemp Dolliver 43 B. Nemeroff 43 Jason Kolbert 43 Adrianne Shapira 43 ANALYST TAKE Credit Suisse 43 Lazard nyse LAZ 43 Analyst Gene Munster 43 Dahlman Rose 43 analyst Jim Birchenough 43 analyst Sara Michelmore 43 www.piperjaffray.com 43 Goldman Sachs nyse GS 43 Mark Astrachan 43 Ehud Gelblum 43 Jason Kantor 43 AmTech Research 43 Tee Sze Chiah 43 Soundview Technology 43 BioCentury NewsMakers 43 Geoff Porges 43 Jon Lecroy 43 Colin Sebastian 43 Reik Read 43 analyst Brent Bracelin 43 & Renshaw Techvest 43 Trevor Polischuk 43 analyst Brad Reback 43 Urs Dur 43 Freidman Billings Ramsey 43 Nasdaq IDIX 43 TranS1 43 analyst Moshe Katri 43 ANALYST TAKE Deutsche 43 Al Kaschalk 43 Kummetz 43 ANALYST TAKE Goldman Sachs 43 Yair Reiner 43 David Turkaly 43 Nasdaq EXAS today 43 Jonathan Aschoff 43 CapStone Investments 43 Natixis Bleichroeder analyst 43 analyst Sumit Dhanda 43 Global Industrials Unplugged 43 Louis Miscioscia 43 Jed Dorsheimer 43 NYSE Amex LTS 43 Morgan Keegan analyst 43 Reiterates Buy rating 43 Piper Jaffrey analyst 43 Nasdaq ANDS announced 43 Lehman Brothers Eleventh 43 Danely 43 Jason Avilio 43 analyst Tal Liani 43 Mahesh Sanganeria 43 UBS 43 peerperform 42 Goldman Sachs JBWere Pty 42 Chief Executive Zev Weiss 42 BIOCOM Investor Conference 42 analyst Dorothy Lakner 42 Stifel Nicolaus Cleantech 42 FTN Equity Capital Markets 42 Liisa Bayko 42 Brent Thill 42 Steve Lidberg 42 Nasdaq ITMN 42 Sanford Bernstein analyst 42 Monane 42 NASDAQ ONXX 42 Harris Nesbitt 42 Todd Raker 42 Benny Lorenzo 42 Goldman Sachs Communacopia XVII 42 Ian Somaiya 42 Dahlman Rose downgraded 42 Le Parker Meridien 42 analyst Deborah Weinswig 42 Glenn Reicin 42 Joseph Osha 42 BIO InvestorForum 42 Squali 42 WestLB Panmure 42 analyst Jason Asaeda 42 Brian Gesuale 42 Robert Spingarn 42 Evolution Beeson Gregory 42 NASDAQ OSIP announced 42 ABN AMRO Incorporated 42 Jeetil Patel 42 Friedman Billings reiterate 42 Enam Securities Private 42 Nasdaq DRRX announced 42 bookrunning manager 42 analyst Jesse Pichel 42 Darren Lehrich 42 Retailing Leaders 42 Fidacaro 42 CJS Securities Investor 42 Equal Weight rating 42 Standpoint Research downgraded 42 analyst Bruce Harting 42 analyst Michael Masdea 42 Kathryn Huberty 42 EdgeWater Research 42 John Calcagnini 42 Ingrid Ebeling 42 John DiFucci 42 Capital Markets Janney Montgomery 42 NYSE PJC 42 JMP Securities JMP 42 Needham 42 Sasa Zorovic 42 Roopesh Patel 42 analyst Mark Lipacis 42 Clyde Montevirgen 42 analyst Ben Reitzes 42 analyst Mehdi Hosseini 42 Wedbush PacGrow Life 42 CSFB 42 Macquarie Equities 42 analyst Christopher Danely 42 Inc. Nasdaq GLCH 42 Gbola Amusa 42 PRNewswire FirstCall DURECT Corporation 42 Barry Tarasoff 42 analyst Amit Daryanani 42 analyst Shaul Eyal 42 Goldman Sachs Communacopia 42 Brion Tanous 42 Catlin Levis Redbook 42 OneMedForum San Francisco 42 Larry Biegelsen 42 analyst Gbola Amusa 42 Goldman Sachs Communacopia XIX 42 JPMorgan SMid Cap 42 analyst Gurinder Kalra 42 Sandeep Aggarwal 42 Steven Harr 42 analyst Budd Bugatch 42 Brian Bapty 42 Benjamin Mogil 42 Maynard Um 42 Renshaw Techvest 7th 42 Christopher Danely 42 Inc. Attn Syndicate 42 RBC Capital Mkts Reiterate 42 Krishna Shankar 42 Healthcare Tailwinds Conference 42 Doug Creutz 42 Annual Needham Growth 42 Edward Najarian 42 Global Industrials 42 analyst Maged Shenouda 42 Small Cap Institutional Investor 42 LifeTech Capital 42 Uche Orji 42 Ittai Kidron 42 Jay Deahna 42 Doug Sipkin 42 ANALYST TAKE 42 analyst Steven Milunovich 42 Michael Exstein 42 Outperform rating 42 Ladenburg Thalmann 42 Natixis Bleichroeder Second 42 Deane Dray 42 Citi Futures Perspective 42 Two Investor Conferences 42 analyst Gregory Badishkanian 42 analyst Yaron Werber 42 Ananda Baruah 42 Rabo Securities 42 Funtleyder 42 William F. Tanona 42 Kaufman Bros reiterate 42 Virginia Genereux 42 Stryker NYSE SYK 42 Tobias Levkovich 42 SEB Enskilda 42 Oriel Securities 42 David Amsellem 42 Altus Pharmaceuticals 42 Panmure Gordon analyst 42 PRNewswire FirstCall InterMune 42 TD Newcrest 42 Arden Partners 42 Miller Tabak 42 Nasdaq BMRN 42 Michael Vinciquerra 42 MKM Partners LP 42 Longbow Research analyst 42 KeyBanc analyst 42 Ben Mogil 42 Goldman Sachs JBWere Pty. 42 Kemp Dolliver 42 Moshe Katri 42 Petercam analyst 41 Calyon Securities analyst 41 Semiannual Micro Cap 41 Goldman Sachs Seventeenth 41 W. Ruttenbur 41 analyst Jeff Fidacaro 41 Sanjiv Wadhwani 41 Overweight rating 41 SIGnificant Investment Options 41 analyst Rick Sherlund 41 Stacey Widlitz analyst 41 Dorothy Lakner 41 James McIlree 41 Krensavage 41 analyst Dan Wantrobski 41 William Tanona 41 BNY Capital Markets 41 Annual LD MICRO 41 analyst Cai von 41 Nasdaq ISTA 41 Canaccord 41 Oppenheimer Industrials 41 Pacific Crest 41 TSRX 41 Financial Institutions Investor 41 analyst Mark Edelstone 41 Stiffel Nicolaus 41 WR Hambrecht reiterates 41 Piper Jaffray downgrades 41 analyst Kian Abouhossein 41 Jeff Van Sinderen 41 Lauri Brunner 41 Geoff Ruddell 41 Andrew Garthwaite 41 Anadys Pharmaceuticals 41 Goldman Sachs Communacopia XVIII 41 FBR Capital Upgrades 41 Pantginis 41 JMP Securities downgrade 41 James Covello 41 analyst Jayson Noland 41 Brad Reback 41 analyst Christopher O'Cull 41 Craig Hallum Institutional Investor 41 Phillip Nalbone 41 Renshaw 9th 41 analyst Edwin Mok 41 Rommel Dionisio 41 JM Dutton 41 Lee Klaskow 41 analyst Amit Bhalla 41 Mark Kalinowski 41 Lipacis 41 analyst Jeffrey Fidacaro 41 ANALYST TAKE Lehman Brothers 41 Bear Stearns SMid Cap 41 Keybanc 41 BancAnalysts Association 41 Andrew Vaino 41 NASDAQ BMTI 41 Richard Fetyko 41 Stern Agee 41 Piper Jaffray reiterate 41 analyst Silke Stegemann 41 S. Drbul 41 analyst Emme Kozloff 41 Ben Reitzes 41 L. Savner 41 analyst Douglas Anmuth 41 analyst Sapna Srivastava 41 Badishkanian 41 Sven Borho partner 41 newratings.com Analyst Jonathan Aschoff 41 analyst Katy Huberty 41 Ltd. SHOO 41 CapStone Investments Third 41 Lazard Capital reiterate 41 Sterne Agee analyst 41 Northcoast Research 41 J. Steven Smigie 41 Troy Mastin 41 NASDAQ ALXN 41 Two Upcoming Investor 41 analyst Farha Aslam 41 Keefe Bruyette & 41 Sanganeria 41 Patrick Walravens 41 analyst Andrey Glukhov 41 Richfield Minn. retailer 41 Inc. Nasdaq ARQL 41 IPAA OGIS San Francisco 41 Inc. NASDAQ ALKS 41 Karl Heinz Koch 41 W Baird 41 TASE RTLX 41 BioMimetic Therapeutics Inc. 41 Johnson Steichen Kinnard 41 Richard Kugele 41 Gary Hsueh 41 Canaccord Genuity Growth 41 BGC Partners LP 41 Nasdaq INCY announced 41 Crowell Weedon & 41 Jeffrey Bencik 41 AmTech 41 ThinkEquity Partners Growth 41 sole underwriter 41 Grofik 41 Dana Telsey 41 Synta Pharmaceuticals 41 Wagonfeld 41 reaffirmed Neutral 41 analyst Hari Sambasivam 41 BernsteinResearch 41 Capital Partners Energize 41 nasdaq HGSI news 41 Avanir Pharmaceuticals 41 newratings.com Analyst Dan Geiman 41 Oscar Gruss 41 Cubist Pharma 41 analyst Laura Champine 41 Corgentech 41 analyst Hamed Khorsand 41 DA Davidson 41 analyst Dean Gianoukos 41 Taglich Brothers 41 Merrill Lynch 41 Jami Rubin 41 analyst Jeffrey Klinefelter 41 analyst Srini Pajjuri 40 Chris Umiastowski 40 analyst Joseph Altobello 40 Institutional Investor Forum 40 Anurag Rana 40 Bill Kreher 40 analyst Gregory Melich 40 Healthcare Tailwinds 40 analyst 40 analyst Kirk Materne 40 Goodbody Stockbrokers 40 WBB Securities 40 Calyon Securities 40 Ren Zamora 40 Sam Fazeli 40 analyst Anthony Noto 40 CFO Adriel Lares 40 Christopher Horvers 40 analyst Laura Conigliaro 40 ThinkEquity Growth 40 Gleacher & 40 PRNewswire FirstCall Medarex 40 Longbow Research 40 ThinkEquity Partners 5th 40 Howe Barnes Hoefer 40 Navdeep Jaikaria 40 Bristol Myers NYSE BMY 40 Mark Bacurin 40 CapStone 40 Idenix Pharmaceuticals 40 Robinson Humphrey 40 Cepheid NASDAQ CPHD 40 ROTH Capital 40 George Grofik 40 analyst Tavis McCourt 40 Allan Mishan 40 analyst Simos Simeonidis 40 DZ Bank 40 Global Markets 40 Evercore Partners 40 Gary Giblen 40 analyst Heather Bellini 40 Olav Zilian 40 Cormark Securities 40 FTN Equity Capital 40 Carl Christensen XPRESSTRADE 40 analyst Michael Exstein 40 AthenaHealth 40 Piper Jaffray downgraded 40 Heather Bellini 40 Stacy Rasgon 40 Nasdaq CELG 40 Aaron Reames 40 analyst Douglas Mavrinac 40 Panmure Gordon stockbrokers 40 analyst Dara Mohsenian 40 Orapred 40 Mark Monane 40 Inc. NASDAQ ITMN 40 Canaccord Genuity Healthy Living 40 NASDAQ GPRO 40 Anton Wahlman 40 Tal Liani 40 Putnam Lovell NBF 40 Market Perform 40 Monolithic Power 40 FTN Midwest Research 40 CFO Tom Szkutak 40 analyst Akshay Jagdale 40 ICR Xchange Conference 40 Intermune 40 RCap Securities Inc. 40 Ragen MacKenzie 40 Mitsubishi UFJ Securities 40 Neutral rating 40 Atul Bagga 40 Peer Perform 40 analyst Douglas Sipkin 40 Creditsights 40 Amylin AMLN 40 Ironwood Pharmaceuticals Inc. 40 Analyst Dan Geiman 40 Brean Murray downgrades 40 analyst Sterling Auty 40 analyst Mario Mendonca 40 Charles Grom 40 Duane Grubert 40 ICR Xchange 40 Kin Ho 40 analyst Arnab Chanda 40 Oppenheimer Yair Reiner 40 Shari Schwartzman Eberts 40 Sal Tharani 40 Standpoint Research 40 analyst Michael Rehaut 40 Tristan Gerra 40 Analyst Safa Rashtchy 40 Tien tsin Huang 40 Singular Research 40 Brett Manderfeld 40 Drew Brosseau 40 Attention Syndicate Prospectus 40 Sidoti Emerging 40 Jefferies Quarterdeck 40 Nasdaq GIII 40 Oriel Securities Ltd. 40 Annual Institutional Investor 40 analyst Jacques Rousseau 40 Budd Bugatch 40 Peter Appert 40 Reiterates Neutral Rating 40 Jeff Kvaal 40 Nikko Citigroup 40 Aegerion Pharmaceuticals Inc. 40 Orbimed Advisors LLC 40 Isaac Ro 40 Holger Blum 40 MF Global 40 Cowen NASDAQ COWN 40 Laura Conigliaro 40 Manuel J. Recarey 40 Eyetech 40 Eyetech Pharmaceuticals 40 Simona Jankowski 40 Zogenix 40 Cihra 40 Kash Rangan 40 NAREIT Investor Forum 40 BioSphere Medical 40 Steve Massocca 40 Nasdaq MAPP 40 UOB KayHian 40 Medicis Pharma 40 Jennifer Fritzsche 40 newratings.com Analyst Kurt Hallead 40 Evercore Partners EVR 40 Geoffrey Porges 40 analyst Alexander Peterc 40 analyst Guy Moszkowski 40 Inc. NASDAQ HGSI 40 Friedman Billings Ramsay 40 analyst Sid Parakh 40 Celgene NASDAQ CELG 40 FBR Capital reiterates 40 analyst Jason Helfstein 40 Northland Capital Markets 40 Mark Schappel 40 orthopedic implant maker 40 analyst Kurt Hallead 40 Small Cap Ideas 40 Analyst Tristan Gerra 40 analyst Peter Lisnic 40 Sidoti Micro Cap 40 Matthew Fassler 40 Neibor 40 R. Shawley 40 Lev Pharmaceuticals 40 Dr. Laikind 40 Cypress Bioscience 40 Vertex VRTX 40 Beder 40 Daniel Scalzi 40 analyst Katherine Styponias 40 PRNewswire FirstCall Amylin Pharmaceuticals 40 Medicis NYSE MRX 40 Bansei Securities 40 Renshaw Annual Global 40 Sandler O'Neill Partners LP 40 Samantha Panella 40 Howard Weil 40 Glenn Schorr 40 Landesbank Rheinland Pfalz 40 Nicholas Landekic 40 Brean Murray maintains 40 Broadpoint Gleacher 40 analyst Phillip Nalbone 40 Gemin X Biotechnologies 40 Jefferies Broadview 40 Keybanc Capital 40 Punk Ziegel 40 CombinatoRx Incorporated NASDAQ CRXX 40 analyst Benjamin Reitzes 40 UBS Leveraged Finance 40 Nick Selvaratnam 40 Charles Minervino 40 Douglas Anmuth 40 Loop Capital Markets 39 Broadpoint Gleacher Securities 39 Suntrust Robinson 39 Douglas Sipkin 39 analyst Elemer Piros 39 analyst Seamus Fernandez 39 analyst Kash Rangan 39 analyst Jonathan Schildkraut 39 Vertex Pharmaceuticals NASDAQ VRTX 39 Rating Reiterated 39 Co. Incorporated Attn 39 Jefferies JEF 39 Edward Yruma 39 Medtech Insight Investment 39 analyst Pablo Zuanic 39 sole bookrunning 39 Maxcor Financial 39 Bebe Stores 39 Bob Drbul 39 Andreas Theisen 39 Ben Abramovitz 39 Shebly Seyrafi 39 Auxilium Pharma 39 Analysts Initiate Coverage 39 Biomarin 39 AG Edwards 39 Phil Skolnick 39 #/#/#- Morgan Stanley [001] 39 Kaufman Bros. LP 39 Analyst Sid Parakh 39 Equinet analyst 39 analyst Apjit Walia 39 Sucden brokers 39 Sector Outperformer 39 Upcoming Investor Conference 39 THE SPARK Jefferies 39 Advest 39 Neutral Weight 39 Nomura Securities 39 Bugatch 39 NYSE MRX 39 Tero Kuittinen 39 Scott Devitt 39 Jason Pflaum 39 William Plovanic 39 THE ANALYSIS 39 Pranjul Bhandari 39 Hans Mosesmann 39 Edelstone 39 Ramon Llamas IDC 39 Simulcast Presentation 39 Bernard Sosnick 39 Varian Semi 39 Jim Reddoch 39 Sepracor SEPR 39 Sector Outperform 39 analyst Glenn Reicin 39 Roxanne Meyer 39 Scott Snyder XPRESSTRADE 39 Donald Fandetti 39 analysts 39 Brian Pitz 39 Sector Performer 39 analyst Jason Gurda 39 Kazaka Securities 39 Peer Perform rating 39 D.A. Davidson 39 BioMarin Pharma 39 Dificid 39 Analyst Ray Neidl 39 NYSE JEF 39 Sipkin 39 Matt Miksic 39 CEOs Unplugged 39 NASDAQ ENDP 39 Fifteenth Annual Emerging 39 NASDAQ APPY 39 S. Gajrawala 39 Mr. Bentsur